By StartupChi Team – November 19, 2024

Introduction

In a significant boost for digital health, Synapticure has raised $25 million in its Series A funding round, aimed at improving access to care for patients suffering from neurodegenerative diseases. This new infusion of capital is pivotal for the company as it ramps up its mission to deliver expert medical attention and continuous support for patients across the United States, even in the most remote areas.

Background

Founded in the throes of the pandemic by a group of passionate health care professionals and technology advocates, Synapticure was born from the recognition that patients with neurodegenerative conditions like Alzheimer’s and Parkinson’s often lack access to specialized care. With the aim of bridging this gap, the company developed a model that not only provides virtual access to expert MDs but also offers a comprehensive 24/7 wrap-around care service. Staying ahead in a rapidly evolving industry, Synapticure stands out in the healthcare landscape by focusing entirely on neurodegenerative diseases, ensuring its offerings are finely tuned to the unique challenges these patients face.

Funding Details

Announced today, the Series A funding round drew participation from notable investors including B Capital and CommonSpirit Health, among others, bringing Synapticure’s total funding to $78.2 million over five funding rounds. Although the pre-money valuation remains undisclosed, the significance of this investment indicates robust investor confidence, particularly in the early-stage venture space within healthcare.

Competitive Landscape

Competing in the neuroscience and wellness sectors, Synapticure’s approach is markedly different from traditional healthcare models. Unlike many competitors who provide generic telehealth services, Synapticure specializes in neurodegenerative disease management, positioning itself as a leader in serving this underserved patient demographic. The combination of medical expertise and holistic care features sets it apart, paving the way for better patient outcomes and satisfaction.

Future Plans

With this new funding, Synapticure plans to enhance its technological framework for patient care, expand its network of medical professionals, and broaden its geographic reach within the United States. The startup is also poised to invest in user experience design and data analytics capabilities to further improve patient engagement and care quality.

As Synapticure embarks on this exciting chapter, the company remains dedicated to transforming the landscape of neurodegenerative care. For more insights into the company’s journey and its innovative solutions, visit www.synapticure.com.

Series A – Synapticure:

• Organization Name: Synapticure
• Organization Description: We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
• Website: www.synapticure.com/
• Funding Type: Series A
• Funding Round: Series A – Synapticure
• Money Raised: $25,000,000
• Announced Date: Nov 19, 2024
• Funding Stage: Early Stage Venture
• Pre-Money Valuation: —
• Equity-Only Funding: Yes
• Industries: Health Care, Medical, Neuroscience, Wellness
• Revenue: $1M to $10M
• Total Funding: $78,245,500
• Funding Status: Early Stage Venture
• Number of Funding Rounds: 5
• Lead Investor:
• Investors: ,,,,,,,, B Capital, , CommonSpirit Health
• Number of Investors: 8
• Number of Partner Investors: 1